Scheme 1From: CRISPR/Cas9 delivery by NIR-responsive biomimetic nanoparticles for targeted HBV therapySchematic illustration of the NIR light-controlled biomimetic nanoplatform for the delivery of Cas9 RNP for HBV gene editingBack to article page